What is LOPJLB’s current signal on CBIO?

LOPJLB’s latest quantitative signal on Crescent Biopharma, Inc. (CBIO) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CBIO in?

Crescent Biopharma, Inc. (CBIO) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Crescent Biopharma, Inc. (CBIO) do?

Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a …

Where is Crescent Biopharma, Inc. based / listed?

Crescent Biopharma, Inc. is based in US, listed on NASDAQ.

Crescent Biopharma, Inc. (CBIO)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$14.12+4.67%Close

SELLCRISIS · day 17

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $389M
Beta: 1.26
P/E (TTM): -1.79

Short % float: 15.98%
Days to cover: 8.5
SI change: +7.4%

1W: -0.98%
1M: -29.36%

vs SPY 1W: -2.54%
vs SPY 1M: -31.13%

Industry peers

FMP comparable companies · ranked by market cap

OABIBUYOmniAb, Inc.$706MCRISISQ -11$4.87+2.19%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news